title: Cyclic AMP-dependent regulation of differentiation of rat C6 glioma cells by panaxydol.
abstract: OBJECTIVE
  Preliminary works have indicated that panaxydol possesses growth inhibition and induces differentiation in rat C6 glioma cells. However, the molecular mechanism underlying this differentiation remains unknown. We sought to investigate the role of cyclic adenosine monophosphate (cAMP) in cellular differentiation induced by panaxydol.
  
  
  METHODS
  C6 cells were treated with panaxydol and various specific inhibitors, and the inhibition of cell growth was assessed by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide assay and homotransplantation in nude mice. Astrocytic processes were quantified under a phase-contrasted microscope. Glial fibrillary acidic protein expression and cell migration were carried out by Western blot and scratch-wound test, respectively. In addition, the intracellular cAMP concentration was measured by immunoassay.
  
  
  RESULTS
  Panaxydol induces the elevation of intracellular cAMP concentration in C6 cells. The effects of growth inhibition in vitro and in vivo and induction of differentiation in C6 cells by panaxydol could be inhibited by the cAMP inhibitor, Rp-adenosine 3',5'-cyclic monophosphothioate, but not by protein kinase A or protein kinase C specific inhibitors.
  
  
  CONCLUSIONS
  These results suggest that the cAMP-dependent pathway may regulate cellular proliferation, migration and differentiation in C6 glioma cells by panaxydol.
authors.affiliation: Department of Neurosurgery, Tongji Hospital, Tongji University, Shanghai, China.
authors.forename: Jian
authors.initials: J
authors.lastname: Hai
authors.forename: Qi
authors.initials: Q
authors.lastname: Lin
authors.forename: Hao
authors.initials: H
authors.lastname: Zhang
authors.forename: Yang
authors.initials: Y
authors.lastname: Lu
authors.forename: Jing
authors.initials: J
authors.lastname: Yi
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000473:pathology; D002454:Cell Differentiation / Q000187:drug effects*; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism*; D053280:Diynes / Q000494:pharmacology*; D005233:Fatty Alcohols / Q000494:pharmacology*; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism*; D005910:Glioma / Q000178:diet therapy / Q000378:metabolism / Q000473:pathology*; D006131:Growth Inhibitors / Q000008:administration & dosage; D008297:Male; D051379:Mice; D008819:Mice, Nude; D051381:Rats; D014407:Tumor Cells, Cultured; D023041:Xenograft Model Antitumor Assays
chemical_list: D053280:Diynes; D005233:Fatty Alcohols; D005904:Glial Fibrillary Acidic Protein; D006131:Growth Inhibitors; C055778:panaxydol; D000242:Cyclic AMP